A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults

NCT06290050 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Midazolam
DRUG: Repaglinide
DRUG: TAK-279

Sponsor

Takeda